JP2004526421A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004526421A5 JP2004526421A5 JP2002542118A JP2002542118A JP2004526421A5 JP 2004526421 A5 JP2004526421 A5 JP 2004526421A5 JP 2002542118 A JP2002542118 A JP 2002542118A JP 2002542118 A JP2002542118 A JP 2002542118A JP 2004526421 A5 JP2004526421 A5 JP 2004526421A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- seq
- proliferation
- polypeptide
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical group 0.000 claims 22
- 201000010099 disease Diseases 0.000 claims 18
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 18
- 229920001184 polypeptide Polymers 0.000 claims 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 230000032823 cell division Effects 0.000 claims 14
- 230000004663 cell proliferation Effects 0.000 claims 14
- 238000000034 method Methods 0.000 claims 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 11
- 230000002159 abnormal effect Effects 0.000 claims 10
- 108020004707 nucleic acids Proteins 0.000 claims 9
- 102000039446 nucleic acids Human genes 0.000 claims 9
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 125000003275 alpha amino acid group Chemical group 0.000 claims 5
- 239000003814 drug Substances 0.000 claims 5
- 229940079593 drug Drugs 0.000 claims 5
- 206010006187 Breast cancer Diseases 0.000 claims 4
- 208000026310 Breast neoplasm Diseases 0.000 claims 4
- 206010009944 Colon cancer Diseases 0.000 claims 4
- 201000000054 Coronary Restenosis Diseases 0.000 claims 4
- 206010056489 Coronary artery restenosis Diseases 0.000 claims 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 4
- 206010025323 Lymphomas Diseases 0.000 claims 4
- 206010033128 Ovarian cancer Diseases 0.000 claims 4
- 206010061535 Ovarian neoplasm Diseases 0.000 claims 4
- 208000029742 colonic neoplasm Diseases 0.000 claims 4
- 239000012634 fragment Substances 0.000 claims 4
- 201000005202 lung cancer Diseases 0.000 claims 4
- 208000020816 lung neoplasm Diseases 0.000 claims 4
- 230000001613 neoplastic effect Effects 0.000 claims 4
- 238000012216 screening Methods 0.000 claims 4
- 238000012300 Sequence Analysis Methods 0.000 claims 2
- 230000000295 complement effect Effects 0.000 claims 2
- 230000001747 exhibiting effect Effects 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 238000002372 labelling Methods 0.000 claims 2
- 239000007790 solid phase Substances 0.000 claims 2
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 230000002163 immunogen Effects 0.000 claims 1
- 230000003993 interaction Effects 0.000 claims 1
- 230000002452 interceptive effect Effects 0.000 claims 1
- 238000002955 isolation Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000011002 quantification Methods 0.000 claims 1
- 238000003259 recombinant expression Methods 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24675000P | 2000-11-09 | 2000-11-09 | |
| PCT/EP2001/013034 WO2002038805A2 (en) | 2000-11-09 | 2001-11-09 | Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004526421A JP2004526421A (ja) | 2004-09-02 |
| JP2004526421A5 true JP2004526421A5 (OSRAM) | 2005-12-22 |
Family
ID=22932039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002542118A Pending JP2004526421A (ja) | 2000-11-09 | 2001-11-09 | 真核細胞分裂遺伝子並びに増殖疾患の診断および処置におけるそれらの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7368248B2 (OSRAM) |
| EP (1) | EP1334123B1 (OSRAM) |
| JP (1) | JP2004526421A (OSRAM) |
| AT (1) | ATE405585T1 (OSRAM) |
| AU (2) | AU2483802A (OSRAM) |
| CA (1) | CA2428438C (OSRAM) |
| DE (1) | DE60135482D1 (OSRAM) |
| DK (1) | DK1334123T3 (OSRAM) |
| WO (1) | WO2002038805A2 (OSRAM) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8202979B2 (en) | 2002-02-20 | 2012-06-19 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| WO2003070918A2 (en) | 2002-02-20 | 2003-08-28 | Ribozyme Pharmaceuticals, Incorporated | Rna interference by modified short interfering nucleic acid |
| US7517864B2 (en) | 2001-05-18 | 2009-04-14 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US9994853B2 (en) | 2001-05-18 | 2018-06-12 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
| US20050148530A1 (en) | 2002-02-20 | 2005-07-07 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA) |
| US9657294B2 (en) | 2002-02-20 | 2017-05-23 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| EP1432724A4 (en) | 2002-02-20 | 2006-02-01 | Sirna Therapeutics Inc | INTERFERENCE MEDIATION INHIBITION OF GENE RNA FROM MAP KINASE |
| US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| WO2005049846A2 (en) * | 2003-11-17 | 2005-06-02 | Crusade Laboratories Limited | Mutant herpes simplex virus and use thereof in the treatment of squamous cell cancer |
| US7858769B2 (en) | 2004-02-10 | 2010-12-28 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using multifunctional short interfering nucleic acid (multifunctional siNA) |
| WO2005105157A2 (en) | 2004-04-23 | 2005-11-10 | The Trustees Of Columbia University In The City Ofnew York | INHIBITION OF HAIRLESS PROTEIN mRNA |
| US10508277B2 (en) | 2004-05-24 | 2019-12-17 | Sirna Therapeutics, Inc. | Chemically modified multifunctional short interfering nucleic acid molecules that mediate RNA interference |
| US9708619B2 (en) | 2005-09-20 | 2017-07-18 | Basf Plant Science Gmbh | Methods for controlling gene expression using ta-siRNA |
| JP5759673B2 (ja) | 2007-03-21 | 2015-08-05 | ブルックヘブン サイエンス アソシエイツ，エルエルシー | 組み合わされたヘアピン−アンチセンス組成物および発現を調節するための方法 |
| KR101605932B1 (ko) | 2009-12-18 | 2016-03-24 | 노파르티스 아게 | Ｈｓｆ1-관련 질환을 치료하기 위한 유기 조성물 |
| US20120296403A1 (en) | 2010-02-10 | 2012-11-22 | Novartis Ag | Methods and compounds for muscle growth |
| EP3327125B1 (en) | 2010-10-29 | 2020-08-05 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of gene expression using short interfering nucleic acids (sina) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8910962D0 (en) | 1989-05-12 | 1989-06-28 | Natural Environment Res | Novel baculovirus expression vectors and use thereof in the expression of foreign proteins in insects or insect cells |
| US5162222A (en) | 1989-07-07 | 1992-11-10 | Guarino Linda A | Use of baculovirus early promoters for expression of foreign genes in stably transformed insect cells or recombinant baculoviruses |
| US5155037A (en) | 1989-08-04 | 1992-10-13 | The Texas A&M University System | Insect signal sequences useful to improve the efficiency of processing and secretion of foreign genes in insect systems |
| CA2311201A1 (en) * | 1999-08-05 | 2001-02-05 | Genset S.A. | Ests and encoded human proteins |
-
2001
- 2001-11-09 CA CA2428438A patent/CA2428438C/en not_active Expired - Fee Related
- 2001-11-09 AT AT01993708T patent/ATE405585T1/de not_active IP Right Cessation
- 2001-11-09 DK DK01993708T patent/DK1334123T3/da active
- 2001-11-09 US US10/415,657 patent/US7368248B2/en not_active Expired - Fee Related
- 2001-11-09 DE DE60135482T patent/DE60135482D1/de not_active Expired - Lifetime
- 2001-11-09 AU AU2483802A patent/AU2483802A/xx active Pending
- 2001-11-09 AU AU2002224838A patent/AU2002224838B9/en not_active Ceased
- 2001-11-09 JP JP2002542118A patent/JP2004526421A/ja active Pending
- 2001-11-09 WO PCT/EP2001/013034 patent/WO2002038805A2/en not_active Ceased
- 2001-11-09 EP EP01993708A patent/EP1334123B1/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004526421A5 (OSRAM) | ||
| Kirchhausen et al. | Structural and functional division into two domains of the large (100-to 115-kDa) chains of the clathrin-associated protein complex AP-2. | |
| Walsh | Proteins: biochemistry and biotechnology | |
| Hedtke et al. | A comprehensive map of human elastin cross‐linking during elastogenesis | |
| JP2004512022A5 (OSRAM) | ||
| JP2005522999A5 (OSRAM) | ||
| CA2428438A1 (en) | Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases | |
| NO984415L (no) | Peptider med antiproliferative egenskaper | |
| JP2004512824A5 (OSRAM) | ||
| JP2001520037A5 (OSRAM) | ||
| WO1998006841A3 (en) | Two human nsp-like proteins | |
| JP2005514923A5 (OSRAM) | ||
| WO1996040040A3 (en) | Thrombin receptor homolog | |
| JP2005512558A5 (OSRAM) | ||
| JP2007526759A5 (OSRAM) | ||
| WO1997044454A3 (en) | Human phospholipase inhibitor | |
| JP2004535161A5 (OSRAM) | ||
| WO1998018822A3 (en) | Novel human lim proteins | |
| JP2008517918A5 (OSRAM) | ||
| WO1998025956A3 (en) | Human GTP-binding proteins | |
| JP2003113111A5 (OSRAM) | ||
| JP2004533848A5 (OSRAM) | ||
| JP2008509659A5 (OSRAM) | ||
| JP2009542243A5 (OSRAM) | ||
| JP2004531226A5 (OSRAM) |